INF55
INF55 is a NoA multidrug resistance pump inhibitor with the activity of inhibiting the NoA pump. The heterocomplex formed by INF55 combined with berberine shows the potential to combat the resistance of bacterial compounds. INF55 can enhance the antibacterial activity of berberine by reducing its efflux. The structural variants of INF55 can show different NoA inhibitory activities, thereby affecting the antibacterial effect of its corresponding heterocomplexes. Different derivatives of INF55 show similar activity in terms of antibacterial dose and effectiveness[1].
Product Specifications
CAS Number
[4993-87-7]
UNSPSC
12352005
Hazard Statement
H302-H317
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/inf55.html
Smiles
O=[N+](C1=CC2=C(NC(C3=CC=CC=C3)=C2)C=C1)[O-]
Molecular Formula
C14H10N2O2
Molecular Weight
238.24
Precautions
P261-P264-P270-P272-P280-P302+P352-P330-P362+P364-P501
References & Citations
[1]On the Mechanism of Berberine-INF55 (5-Nitro-2-phenylindole) Hybrid Antibacterials
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human GRIA1 sgRNA gene knockout kit - Lentiviral human GRIA1 sgRNA gene knockout kit (100)
Lentiviral mouse Sit1 shRNA (UAS) - Lentiviral mouse Sit1 shRNA (UAS, GFP) (100)
